Information PortalData PortalKnowledge Portal

Data Matrix

Tools & Workflows

Documentation

2254.77 (Glytoucan)

Id:cc49480b-cf86-508a-9740-483b094e957d

Glytoucan:G19786BU

Results found

Linked to

	Label	Description
	2254.77 has glycosequence GLYGEN.GLYCOSEQUENCE:G51087ZL-GLYCOSEQ00186668 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2254.77 has glycosequence GLYGEN.GLYCOSEQUENCE:G08298VG-GLYCOSEQ00138890 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2254.77 has glycosequence GLYGEN.GLYCOSEQUENCE:G02433XU-GLYCOSEQ00029954 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2254.77 has glycosequence GLYGEN.GLYCOSEQUENCE:G57914GV-GLYCOSEQ00196899 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2254.77 has glycosequence GLYGEN.GLYCOSEQUENCE:G46470AD-GLYCOSEQ00017955 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2254.77 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000073 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2254.77 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000003 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2254.77 has glycosequence GLYGEN.GLYCOSEQUENCE:G29248WR-GLYCOSEQ00046921 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2254.77 has canonical residue n-glycan b-d-glcpnac 2 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2254.77 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000004 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2254.77 has glycosequence GLYGEN.GLYCOSEQUENCE:G51087ZL-GLYCOSEQ00186668 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2254.77 has glycosequence GLYGEN.GLYCOSEQUENCE:G08298VG-GLYCOSEQ00138890 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2254.77 has glycosequence GLYGEN.GLYCOSEQUENCE:G02433XU-GLYCOSEQ00029954 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2254.77 has glycosequence GLYGEN.GLYCOSEQUENCE:G57914GV-GLYCOSEQ00196899 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2254.77 has glycosequence GLYGEN.GLYCOSEQUENCE:G46470AD-GLYCOSEQ00017955 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2254.77 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000073 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2254.77 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000003 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2254.77 has glycosequence GLYGEN.GLYCOSEQUENCE:G29248WR-GLYCOSEQ00046921 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2254.77 has canonical residue n-glycan b-d-glcpnac 2

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2254.77 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000004 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.